via Fox Business This week Johnson & Johnson announced the beginning of Phase 3 trials of their SARS-Cov-2 vaccine, becoming the fourth company as part of “Operation Warp Speed” to enter this advanced stage of testing With plans to enroll up to 60,000 subjects,...
via Adobe Stock Photos Many of the leading vaccine candidates in development (eg Moderna, Pfizer, Sanofi) are based upon injection of DNA or RNA genetic material that is taken up into the body’s cells, programmed to produce SARS-CoV-2 viral proteins, and then generate...
via AP Images While there are more than 150 vaccines in development worldwide, one of the more recent candidates could be a frontrunner within a few short months. Despite more sensational study results from competitors with an earlier start, Sanofi Pasteur has...
via Unsplash Regeneron Pharmaceuticals Inc., a US-based biotechnology company, recently announced exciting results from two animal studies testing its COVID-19 antibody drug formulation. Utilizing its proprietary platform called “VelocImmune”, the company is able to...
via Novavax This week there was another encouraging report in the race to develop a vaccine to the SARS-CoV-2 virus. Novavax, a small company that recently made news as a recipient of $1.6 billion by the White House “Operation Warp Speed”, just released its...
via Adobe Stock Photos The COVID-19 virus has continued to spread throughout the United States, with an alarming increase in new cases no longer contained to mostly urban hotspots. This underscores the need for all Americans to continue exercising proper precautions,...
